1. Home
  2. KROS vs LINC Comparison

KROS vs LINC Comparison

Compare KROS & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • LINC
  • Stock Information
  • Founded
  • KROS 2015
  • LINC 1946
  • Country
  • KROS United States
  • LINC United States
  • Employees
  • KROS N/A
  • LINC N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • LINC Other Consumer Services
  • Sector
  • KROS Health Care
  • LINC Real Estate
  • Exchange
  • KROS Nasdaq
  • LINC Nasdaq
  • Market Cap
  • KROS 460.6M
  • LINC 499.3M
  • IPO Year
  • KROS 2020
  • LINC 2005
  • Fundamental
  • Price
  • KROS $11.00
  • LINC $17.12
  • Analyst Decision
  • KROS Buy
  • LINC Strong Buy
  • Analyst Count
  • KROS 11
  • LINC 4
  • Target Price
  • KROS $45.33
  • LINC $18.00
  • AVG Volume (30 Days)
  • KROS 2.1M
  • LINC 113.6K
  • Earning Date
  • KROS 02-26-2025
  • LINC 02-24-2025
  • Dividend Yield
  • KROS N/A
  • LINC N/A
  • EPS Growth
  • KROS N/A
  • LINC N/A
  • EPS
  • KROS N/A
  • LINC 0.32
  • Revenue
  • KROS $651,000.00
  • LINC $423,213,000.00
  • Revenue This Year
  • KROS $303.27
  • LINC $16.43
  • Revenue Next Year
  • KROS N/A
  • LINC $8.66
  • P/E Ratio
  • KROS N/A
  • LINC $53.55
  • Revenue Growth
  • KROS 8037.50
  • LINC 15.21
  • 52 Week Low
  • KROS $9.78
  • LINC $9.29
  • 52 Week High
  • KROS $73.00
  • LINC $18.74
  • Technical
  • Relative Strength Index (RSI)
  • KROS 24.79
  • LINC 66.58
  • Support Level
  • KROS $11.04
  • LINC $15.83
  • Resistance Level
  • KROS $11.99
  • LINC $16.44
  • Average True Range (ATR)
  • KROS 0.60
  • LINC 0.44
  • MACD
  • KROS 1.20
  • LINC 0.12
  • Stochastic Oscillator
  • KROS 43.99
  • LINC 97.92

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services and business and information technology. Its reportable segments include; Campus Operations, and Transitional. Majority of the revenue is generated from Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

Share on Social Networks: